In the media
September 5, 2023
(French) Federated learning, the future of data-driven medicine
Research into artificial intelligence (AI), and in particular progress in machine learning and deep learning, has enabled the emergence of disruptive innovations, particularly in radiology.
Share to:
About Owkin
Owkin is an agentic AI company pioneering Biological Artificial Superintelligence to solve problems in biology where human researchers alone have failed.
Owkin builds K Pro - an AI scientist for pharmaceutical research and strategic decision-making. K Pro orchestrates a suite of AI skills and tools to decode complex biology, accelerate research, and dramatically increase productivity.
K Pro is built on Owkin’s unrivalled multimodal patient data network, state-of-the-art AI for biology and a decade of experience working with pharmaceutical partners.
